当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析 - 利润表

双鹭药业

(002038)

  

流通市值:113.03亿  总市值:136.33亿
流通股本:8.52亿   总股本:10.27亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312019-09-302019-06-30
一、营业总收入194,660,284.32,029,703,659.831,575,830,436.241,050,284,654.23
营业收入194,660,284.32,029,703,659.831,575,830,436.241,050,284,654.23
二、营业总成本148,041,020.191,531,319,950.071,088,154,389.96713,095,222.77
营业成本24,169,612.96417,379,069.18306,138,114.11201,403,981.75
营业税金及附加1,827,503.0223,061,038.4718,284,054.2613,667,372.71
销售费用64,718,214.6890,226,770.26636,687,728.38413,268,787.02
管理费用18,752,651.7797,536,728.8873,623,740.4350,177,988.37
财务费用10,540,168.18-25,236,541.13-28,819,513.78-11,060,370.95
资产减值损失--------
三、其他经营收益6,618,228.333,728,584.14-8,736,049.743,134,918.67
允许价值变动净收益7,873,778.3413,699,791.072,574,0863,848,386
投资净收益11,951,821.3932,101,992.7727,001,469.3119,628,285.61
联营、合营企业投资收益-21,709.07-6,466,240.09-21,709.07-21,709.07
汇兑净收益--------
四、营业利润66,456,836.55560,901,003.22564,542,058.05402,601,731.96
营业外收入59,398.48------
营业外支出103,309.5312,924.25----
非流动资产处置净损失--------
五、利润总额66,412,925.5560,888,078.97564,542,058.05402,601,731.96
所得税6,268,059.5781,389,86668,878,050.5151,504,675.66
未确认的投资损失--------
六、净利润(百万元)61.58486.78503.04356.85
少数股东损益-1,437,952.28-7,285,410.42-7,378,589.44-5,757,788.74
归属于母公司股东的净利润61,582,818.21486,783,623.39503,042,596.98356,854,845.04
七、每股收益0.060.470.490.52
基本每股收益0.060.470.490.52
稀释每股收益0.060.470.490.52
TOP↑